{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-077430","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.913820+00:00","generated_at":"2026-05-31T23:44:28.774401+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Sagimet updates investor presentation; no material financial or clinical data changes","bullets":["Company filed updated slide presentation for investor meetings dated July 2, 2024.","Presentation covers pipeline programs in MASH, acne, and cancer.","No specific new results, guidance, or material developments were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-077430","json":"https://secwatch.observer/filing/0001104659-24-077430.json","markdown":"https://secwatch.observer/filing/0001104659-24-077430.md","text":"https://secwatch.observer/filing/0001104659-24-077430.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924077430/0001104659-24-077430-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924077430/tm2418784d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:44:28.774401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}